Portal de Periódicos da CAPES

Raynaud’s Phenomenon after Combined Adjuvant Chemotherapy for Breast Cancer

2003; Karger Publishers; Volume: 49; Issue: 5 Linguagem: Inglês

10.1159/000072453

1421-9794

Rossella De Angelis, F Silveri, Leonardo Bugatti, Giorgio Filosa,

Chemotherapy-related skin toxicity

Letters| September 25 2003 Raynaud's Phenomenon after Combined Adjuvant Chemotherapy for Breast Cancer Subject Area: Further Areas , Oncology , Pharmacology Rossella De Angelis; Rossella De Angelis Department of Rheumatology, University of Ancona, Ancona, and Search for other works by this author on: This Site PubMed Google Scholar Ferdinando Silveri; Ferdinando Silveri Department of Rheumatology, University of Ancona, Ancona, and Search for other works by this author on: This Site PubMed Google Scholar Leonardo Bugatti; Leonardo Bugatti Dermatology Unit, 'Augusto Murri' Hospital, Jesi, Italy Search for other works by this author on: This Site PubMed Google Scholar Giorgio Filosa Giorgio Filosa Dermatology Unit, 'Augusto Murri' Hospital, Jesi, Italy Search for other works by this author on: This Site PubMed Google Scholar Chemotherapy (2003) 49 (5): 267–268. https://doi.org/10.1159/000072453 Article history Published Online: September 25 2003 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Rossella De Angelis, Ferdinando Silveri, Leonardo Bugatti, Giorgio Filosa; Raynaud's Phenomenon after Combined Adjuvant Chemotherapy for Breast Cancer. Chemotherapy 1 September 2003; 49 (5): 267–268. https://doi.org/10.1159/000072453 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsChemotherapy Search Advanced Search This content is only available via PDF. 2003Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Article PDF first page preview Close Modal You do not currently have access to this content.